Moxifloxacin (Avelox) for the treatment of bacterial skin infections.
Moxifloxacin (Avelox, Bayer), which is available for oral administration, is a broad-spectrum synthetic antimicrobial agent with excellent Gram-positive activity and good Gram-negative activity. The US FDA recently approved this drug for the treatment of bacterial skin infections.
Parish
L C
LC
Departments of Dermatology and Cutaneous Biology, Jefferson Medical Colege, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Witkowski
J A
JA
Routh
H B
HB
D000890:Anti-Infective Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001372:Aza Compounds; D024841:Fluoroquinolones; D006801:Humans; D000077266:Moxifloxacin; D011804:Quinolines; D017192:Skin Diseases, Bacterial / Q000188:drug therapy*
D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin